Global Gene Editing Technology Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Latest Trends
Publisher : MRA | Format : PDF
Global Gene Editing Technology Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application
Gene editing is a new and accurate genetic engineering technology that can modify specific target genes in the genome of an organism.
Gene editing technology refers to the ability for humans to "edit" targeted genes to achieve modifications to specific DNA fragments.
Gene editing relies on genetically engineered nucleases, also known as "molecular scissors," to produce site-specific double-strand breaks (DSBs) at specific locations in the genome, inducing organisms to connect via non-homologous end junctions (NHEJ) or homologous Source Recombination (HR) to repair DSB because this repair process is error-prone, resulting in targeted mutations
Gene Editing Technology report published by MRA Research reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2023. Global Gene Editing Technology market is projected to reach US$ million in 2033, increasing from US$ million in 2023, with the CAGR of % during the period of 2023 to 2033. Demand from Agriculture and Medical are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Gene Editing Technology industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2023 to 2033.
Globally, Gene Editing Technology key companies include Thermo Fisher Scientific, SIGMA ALDRICH, Dharmacon, Cellectics, CRISPR Therapeutics, AstraZeneca, Bio Rad, Allele Biotech and Recombinetics, etc. Thermo Fisher Scientific, SIGMA ALDRICH, Dharmacon are top 3 players and held % share in total in 2023.
Gene Editing Technology can be divided into Homologous Recombination and Meganuclease, etc. Homologous Recombination is the mainstream product in the market, accounting for % share globally in 2023.
Gene Editing Technology is widely used in various fields, such as Agriculture, Medical and Other,, etc. Agriculture provides greatest supports to the Gene Editing Technology industry development. In 2023, global % share of Gene Editing Technology went into Agriculture filed.
Report Scope
This report, based on historical analysis (2018-2023) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Gene Editing Technology market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report
Thermo Fisher Scientific
SIGMA ALDRICH
Dharmacon
Cellectics
CRISPR Therapeutics
AstraZeneca
Bio Rad
Allele Biotech
Recombinetics
Lonza
GE Healthcare
Editas Medicine
Agilent Technologies
QIAGEN NV
Segment by Type
Homologous Recombination
Meganuclease
Agriculture
Medical
Other
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Gene Editing Technology market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2033).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Gene Editing Technology introduction, etc. Gene Editing Technology Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12MRA Research’s Conclusions of Gene Editing Technology market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by MRA Research.
Gene editing technology refers to the ability for humans to "edit" targeted genes to achieve modifications to specific DNA fragments.
Gene editing relies on genetically engineered nucleases, also known as "molecular scissors," to produce site-specific double-strand breaks (DSBs) at specific locations in the genome, inducing organisms to connect via non-homologous end junctions (NHEJ) or homologous Source Recombination (HR) to repair DSB because this repair process is error-prone, resulting in targeted mutations
Gene Editing Technology report published by MRA Research reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2023. Global Gene Editing Technology market is projected to reach US$ million in 2033, increasing from US$ million in 2023, with the CAGR of % during the period of 2023 to 2033. Demand from Agriculture and Medical are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Gene Editing Technology industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2023 to 2033.
Globally, Gene Editing Technology key companies include Thermo Fisher Scientific, SIGMA ALDRICH, Dharmacon, Cellectics, CRISPR Therapeutics, AstraZeneca, Bio Rad, Allele Biotech and Recombinetics, etc. Thermo Fisher Scientific, SIGMA ALDRICH, Dharmacon are top 3 players and held % share in total in 2023.
Gene Editing Technology can be divided into Homologous Recombination and Meganuclease, etc. Homologous Recombination is the mainstream product in the market, accounting for % share globally in 2023.
Gene Editing Technology is widely used in various fields, such as Agriculture, Medical and Other,, etc. Agriculture provides greatest supports to the Gene Editing Technology industry development. In 2023, global % share of Gene Editing Technology went into Agriculture filed.
Report Scope
This report, based on historical analysis (2018-2023) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Gene Editing Technology market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report
By Company
Thermo Fisher Scientific
SIGMA ALDRICH
Dharmacon
Cellectics
CRISPR Therapeutics
AstraZeneca
Bio Rad
Allele Biotech
Recombinetics
Lonza
GE Healthcare
Editas Medicine
Agilent Technologies
QIAGEN NV
Segment by Type
Homologous Recombination
Meganuclease
Segment by Application
Agriculture
Medical
Other
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Gene Editing Technology market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2033).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Gene Editing Technology introduction, etc. Gene Editing Technology Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12MRA Research’s Conclusions of Gene Editing Technology market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by MRA Research.